Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06672952 · ClinicalTrials.gov registry record · NA

Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators

A NA study of Cognitive Function and Exercise Performance, sponsored by Lindenwood University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06672952 is a NA study of Cognitive Function and Exercise Performance that is actively recruiting participants, run by Lindenwood University. The registered enrollment target is 60 participants, below the 495-participant average among 20 other Cognitive Function trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06672952, a NA study of Cognitive Function and Exercise Performance, is actively recruiting participants, sponsored by Lindenwood University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.

Conditions Studied

Cognitive Function Exercise Performance Nitric Oxide Blood Flow Exercise Recovery Endurance Exercise

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT 400 mg CITRAPEAK® (glucosyl-hesperidin) supplementation
  • DIETARY_SUPPLEMENT 200 mg CITRAPEAK® (glucosyl-hesperidin) supplementation

Study Locations (1)

Missouri

  • Lindenwood University - Saint Charles

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-04-15
Est. Completion 2026-01-01
Phase NA

Sponsor

Lindenwood University

29 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06672952

The ClinicalTrials.gov registry entry for NCT06672952 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 495-participant average among 20 other Cognitive Function trials with a reported enrollment target (88% lower). The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Cognitive Function appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06672952 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06672952 about?

NCT06672952 is a clinical study titled "Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators". The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.

What is the current status of trial NCT06672952?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-04-15. Estimated completion is 2026-01-01.

What conditions does trial NCT06672952 study?

This clinical trial studies the following conditions: Cognitive Function, Exercise Performance, Nitric Oxide, Blood Flow, Exercise Recovery.

What interventions are being tested in trial NCT06672952?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 400 mg CITRAPEAK® (glucosyl-hesperidin) supplementation (DIETARY_SUPPLEMENT), 200 mg CITRAPEAK® (glucosyl-hesperidin) supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06672952?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06672952 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cognitive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cognitive Function

All registered trials for this condition

Exercise Performance

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.